RxDoctor Payments Data

Glen Kaiser, MD

Anesthesiology · New Britain, CTNPI 1801814082

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,200 of the $4,107 with a category attached, or 77.9%. Novartis accounts for 77.9% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2020 at $1,700 and has fallen 95.8% since, to $71 in 2025. Among anesthesiology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,107in general payments, 2019–2025

Across 46 payments — averaging $89.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$3K
  • Merck$357
  • Johnson & Johnson$228
  • Intercept Pharmaceuticals, Inc.$122
  • Takeda Pharmaceuticals U.S.A., Inc.$51
  • Daiichi Sankyo Inc.$46
  • plus $104 from 4 others

What the payments were for

  • Consulting fees$3,20078%
  • Food & beverage$90722%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,107 in reported general payments places this provider in the 95th percentile of 664 anesthesiology providers in Connecticut.

See all anesthesiology providers in Connecticut

Medicare billing

Part B allowed, 2024
$10,248
Medicare patients
160
Services billed
162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in New Britain

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →